Evaluation of disintegrating time of rapidly disintegrating tablets by a paddle method

被引:20
作者
Que, Li [1 ]
Wu, Wei [1 ]
Cheng, Xiaofeng [1 ]
Hu, Tao [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 200032, Peoples R China
关键词
rapidly disintegrating tablet; compression; rizatriptan benzoate; paddle method; validation; optimization; factorial design; response surface;
D O I
10.1080/10837450600767649
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
A paddle method for measurement of the disintegrating time of orally disintegrating tablets with rizatriptan benzoate as a model drug was evaluated. The paddle method employed a dissolution test assembly with tablets immersed in disintegrating medium through a fastened sinker. Paddle stirring rate, opening of the sinker sieve, and tablet crushing strength influenced disintegrating time greatly. A logarithmic relationship was observed between disintegrating time and paddle revolution speed, while disintegrating time values and tablet crushing strength were fitted to a linear equation. The paddle method values with limited deviation were in good correlation with in vivo results. The paddle method was employed to optimize the disintegrating time of rizatriptan benzoate orally disintegrating tablets using a factorial design. The best-fit quadratic equation with a regression coefficient of 0.996 was highly predictive, which was indicative that the paddle method was precise and applicable in formulation optimization.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 16 条
[1]
Bi YX, 1996, CHEM PHARM BULL, V44, P2121
[2]
Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization [J].
Bi, YX ;
Yonezawa, Y ;
Sunada, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (10) :1004-1010
[3]
Evaluation of rapidly disintegrating tablets prepared by a direct compression method [J].
Bi, YX ;
Sunada, H ;
Yonezawa, Y ;
Danjo, K .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (05) :571-581
[4]
CHERUKURI SR, Patent No. 5587172
[5]
Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug [J].
Corveleyn, S ;
Remon, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 152 (02) :215-225
[6]
In vitro determination of disintegration time of quick-dissolve tablets using a new method [J].
Dor, PJM ;
Fix, JA .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2000, 5 (04) :575-577
[7]
Evaluation of disintegration testing of different fast dissolving tablets using the texture analyzer [J].
El-Arini, SK ;
Clas, SD .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2002, 7 (03) :361-371
[8]
Habib W, 2000, CRIT REV THER DRUG, V17, P61
[9]
JACCARD TT, 1985, ANN PHARM FR, V43, P123
[10]
Sastry, 2000, Pharm Sci Technol Today, V3, P138